College of Nursing, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Department of Biobehavioral Nursing Science, College of Nursing, University of Florida, Gainesville, Florida, USA.
Cancer Rep (Hoboken). 2023 Jun;6(6):e1833. doi: 10.1002/cnr2.1833. Epub 2023 May 12.
Psychological distress is associated with worsening symptoms during the active treatment period and lower quality of life in women with early-stage breast cancer. Many studies have indicated risk for heightened psychological distress across the breast cancer trajectory.
The aim of this review is to examine the literature for instruments used to measure psychological distress among women with breast cancer during chemotherapy.
This study used the Arksey and O'Malley framework of scoping reviews. Two databases, PubMed & CINAHL, were searched for peer-reviewed original articles that were published within the last ten years, included participants with a diagnosis of breast cancer stages I to III, and receiving chemotherapy, English text articles, and studies that report psychological distress measures.
The initial screening yielded 529 relevant studies. After applying the exclusion criteria, a total of 17 studies concerning the assessment of psychological distress during chemotherapy were retained for the analysis of variables and measures of psychological distress. The instruments used to measure psychological distress varied, with a total of 21 measures. The most frequently utilized measure was the Hospital Anxiety and Depression Scale (n = 5), followed by the Impact of Event Scale (n = 2), the Distress Thermometer (n = 2), and the Perceived Stress Scale (n = 2).
This review identified the gaps related to inconsistencies in the operationalization and instruments used to measure psychological distress among breast cancer survivors during chemotherapy. Standardization of measures assessing psychological distress, along with conceptual clarity, is essential for measuring distress in research and clinical practice.
心理困扰与早期乳腺癌女性在积极治疗期间症状恶化和生活质量下降有关。许多研究表明，乳腺癌病程中存在心理困扰风险增加的情况。
本综述旨在检查评估接受化疗的乳腺癌女性心理困扰的文献中使用的工具。
本研究采用 Arksey 和 O'Malley 的范围综述框架。在 PubMed 和 CINAHL 两个数据库中搜索了过去十年发表的同行评审原始文章，这些文章纳入了乳腺癌 I 至 III 期诊断并接受化疗的参与者、英文文本文章，以及报告心理困扰测量的研究。
最初的筛选产生了 529 篇相关研究。在应用排除标准后，共有 17 项关于化疗期间心理困扰评估的研究被保留下来，用于分析心理困扰的变量和测量方法。用于测量心理困扰的工具各不相同，共有 21 种。使用最多的测量工具是医院焦虑和抑郁量表（n=5），其次是事件影响量表（n=2）、困扰温度计（n=2）和感知压力量表（n=2）。
本综述确定了与化疗期间乳腺癌幸存者心理困扰的操作化和工具使用不一致相关的差距。评估心理困扰的测量工具的标准化以及概念的明确性对于研究和临床实践中的痛苦测量至关重要。
